Innovotech Stock Performance

IOT Stock  CAD 0.19  0.01  5.56%   
On a scale of 0 to 100, Innovotech holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 2.09, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Innovotech will likely underperform. Please check Innovotech's sortino ratio, skewness, relative strength index, as well as the relationship between the potential upside and day median price , to make a quick decision on whether Innovotech's current trending patterns will revert.

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Innovotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Innovotech showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Innovotech Inc. Expands with Keystone Labs Acquisition - TipRanks
09/11/2024
2
Innovotech Reports Record Revenue Growth - TipRanks
11/19/2024
Begin Period Cash Flow469.1 K
Free Cash Flow-271 K
  

Innovotech Relative Risk vs. Return Landscape

If you would invest  14.00  in Innovotech on August 27, 2024 and sell it today you would earn a total of  4.00  from holding Innovotech or generate 28.57% return on investment over 90 days. Innovotech is currently producing 0.5406% returns and takes up 5.5214% volatility of returns over 90 trading days. Put another way, 49% of traded stocks are less volatile than Innovotech, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Innovotech is expected to generate 7.11 times more return on investment than the market. However, the company is 7.11 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of risk.

Innovotech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Innovotech, and traders can use it to determine the average amount a Innovotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0979

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsIOT
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.52
  actual daily
49
51% of assets are more volatile

Expected Return

 0.54
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.1
  actual daily
7
93% of assets perform better
Based on monthly moving average Innovotech is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innovotech by adding it to a well-diversified portfolio.

Innovotech Fundamentals Growth

Innovotech Stock prices reflect investors' perceptions of the future prospects and financial health of Innovotech, and Innovotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innovotech Stock performance.

About Innovotech Performance

Evaluating Innovotech's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Innovotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innovotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company was incorporated in 2001 is headquartered in Edmonton, Canada. INNOVOTECH INC operates under Biotechnology classification in Exotistan and is traded on Commodity Exchange.

Things to note about Innovotech performance evaluation

Checking the ongoing alerts about Innovotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innovotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Innovotech is way too risky over 90 days horizon
Innovotech has some characteristics of a very speculative penny stock
Innovotech appears to be risky and price may revert if volatility continues
The company reported the revenue of 1.18 M. Net Loss for the year was (157.58 K) with profit before overhead, payroll, taxes, and interest of 1.12 M.
Innovotech has accumulated about 602.87 K in cash with (228.08 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 44.0% of the company shares are held by company insiders
Latest headline from news.google.com: Innovotech Reports Record Revenue Growth - TipRanks
Evaluating Innovotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Innovotech's stock performance include:
  • Analyzing Innovotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innovotech's stock is overvalued or undervalued compared to its peers.
  • Examining Innovotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Innovotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innovotech's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Innovotech's stock. These opinions can provide insight into Innovotech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Innovotech's stock performance is not an exact science, and many factors can impact Innovotech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Innovotech Stock Analysis

When running Innovotech's price analysis, check to measure Innovotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovotech is operating at the current time. Most of Innovotech's value examination focuses on studying past and present price action to predict the probability of Innovotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovotech's price. Additionally, you may evaluate how the addition of Innovotech to your portfolios can decrease your overall portfolio volatility.